Journal Published Findings of 2a

$Hepion Pharmaceuticals(HEPA.US)$ announced that their 2a trial findings have been published in the journal Hepatology Communications. In those findings the mention Pro-C3 reduction levels in a 28 day period that other drugs/studies take a minimum of over 3 months to achieve.